Expression of microRNAs in the urinary sediment of patients with IgA nephropathy

Disease Markers

Volumn 28, Issue 2, 2010, Pages 79-86

  Wang, Gang ^a   Kwan, Bonnie Ching Ha ^a   Lai, Fernand Mac Moune ^a   Chow, Kai Ming ^a   Kam Tao Li, Philip ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

biomarker; Glomerulonephritis; proteinuria

Indexed keywords

MICRORNA; VIMENTIN; BIOLOGICAL MARKER; MIRN200 MICRORNA, HUMAN; MIRN429 MICRORNA, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; URINALYSIS; URINE SEDIMENT; CASE CONTROL STUDY; GENETICS; GLOMERULUS FILTRATION RATE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; URINE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS;

EID: 77954042328     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0687     Document Type: Article

References (29)

1. J.V. Donadio and J.P. Grande, IgA nephropathy, N Engl J Med 347(10) (2002), 738-748.
2. R.J. Wyatt, B.A. Julian, D.B. Bhathena, B.L. Mitchell, N.H. Holland and H.H. Malluche, Iga nephropathy: presentation, clinical course, and prognosis in children and adults, Am J Kidney Dis 4(2) (1984), 192-200.
3. G. D'Amico, Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors, Am J Kidney Dis 36(2) (2000), 227-237.
4. H.T. Cook, Interpretation of renal biopsies in IgA nephropathy, Contrib Nephrol 157 (2007), 44-49.
5. B. Julian, R. Wyatt, K. Matousovic, Z. Moldoveanu, J. Mestecky and J. Novak, IgA Nephropathy: A Clinical Overview, Tomino Y (ed): IgA Nephropathy Today Contrib Nephrol Basel, Karger 157 (2007), 19-26.
6. T. Muthukumar, D. Dadhania, R. Ding, C. Snopkowski, R. Naqvi, J.B. Lee, C. Hartono, B. Li, V.K. Sharma, S.V. Seshan et al., Messenger RNA for FOXP3 in the urine of renalallograft recipients, NEngl J Med 353(22) (2005), 2342-2351.
7. G. Wang, F.M. Lai, K.B. Lai, K.M. Chow, B.C. Kwan, P.K. Li and C.C. Szeto, Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker, Eur J Endocrinol 158(3) (2008), 317-322.
8. C.C. Szeto, R.W. Chan, K.B. Lai, C.Y. Szeto, K.M. Chow, P.K. Li and F.M. Lai, Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases, Nephrol Dial Transplant 20(1) (2005), 105-113.
9. R.C. Lee, R.L. Feinbaum and V. Ambros, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5) (1993), 843-854.
10. W.P. Kloosterman and R.H. Plasterk, The diverse functions of microRNAs in animal development and disease, Dev Cell 11(4) (2006), 441-450.
11. G. Ruvkun, The perfect storm of tiny RNAs, Nat Med 14(10) (2008), 1041-1045.
12. P.A. Gregory, C.P. Bracken, A.G. Bert and G.J. Goodall, MicroRNAs as regulators of epithelial-mesenchymal transition, Cell Cycle 7(20) (2008), 3112-3118.
13. E.L. Paterson, N. Kolesnikoff, P.A. Gregory, A.G. Bert, Y. Khew-Goodall and G.J. Goodall, The microRNA-200 family regulates epithelial to mesenchymal transition, Scientific-WorldJournal 8 (2008), 901-904.
14. C.P. Bracken, P.A. Gregory, N. Kolesnikoff, A.G. Bert, J. Wang, M.F. Shannon and G.J. Goodall, A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition, Cancer Res 68(19) (2008), 7846-7854.
15. M. Kato, J. Zhang, M. Wang, L. Lanting, H. Yuan, J.J. Rossi and R. Natarajan, MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors, Proc Natl Acad Sci USA 104(9) (2007), 3432-3437.
16. Y. Nishitani, M. Iwano, Y. Yamaguchi, K. Harada, K. Nakatani, Y. Akai, T. Nishino, H. Shiiki, M. Kanauchi, Y. Saito et al., Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN, Kidney Int 68(3) (2005), 1078-1085.
17. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers and D. Roth, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med 130(6) (1999), 461-470.
18. W. Mitch, Measuring the rate of progression of renal insuffi-ciency, in: The Progressive Nature of Renal Disease, edited by W.E. Mitch, J. Stein and B.M. Brenner, New York, Churchill Livingstone Inc, 1986, pp. 203-220.
19. S. Bhandari, N. Watson, E. Long, S. Sharpe, W. Zhong, S.Z. Xu and S.L. Atkin, Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney, J Histochem Cytochem 56(8) (2008), 733-743.
20. AppliedBiosystems: Endogenous Controls for Real-Time Quantitation of miRNA Using TaqMan MicroRNA Assays, Application Note TaqMan MicroRNA Assays, 2007.
21. N. Rifai, M.A. Gillette and S.A. Carr, Protein biomarker discovery and validation: the long and uncertain path to clinical utility, Nat Biotechnol 24(8) (2006), 971-983.
22. Y. Xi, G. Nakajima, E. Gavin, C.G. Morris, K. Kudo, K. Hayashi and J. Ju, Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples, RNA 13(10) (2007), 1668-1674.
23. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen et al., Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA 105(30) (2008), 10513-10518.
24. R.S. Pillai, MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11(12) (2005), 1753-1761.
25. Q. Wang, Y. Wang, A.W. Minto, J. Wang, Q. Shi, X. Li and R.J. Quigg, MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy, FASEB J 22(12) (2008), 4126-4135.
26. P. Pandey, B. Brors, P.K. Srivastava, A. Bott, S.N. Boehn, H.J. Groene and N. Gretz, Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease, BMC Genomics 9(1) (2008), 624.
27. W. Sui, Y. Dai, Y. Huang, H. Lan, Q. Yan and H. Huang, Microarray analysis of MicroRNA expression in acute rejection after renal transplantation, Transpl Immunol 19(1) (2008), 81-85.
28. Y. Dai, W. Sui, H. Lan, Q. Yan, H. Huang and Y. Huang, Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients, Rheumatol Int, 2008.
29. M. Hara, T. Yanagihara and I. Kihara, Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schonlein-Henoch purpura nephritis, Clin J Am Soc Nephrol 2(2) (2007), 231-238.